Woodcock, Marks Recusals From COVID-19 Product Reviews 'Protect FDA's Reputation'

 
• By Brenda Sandburg

FDA experts say there is deep bench in CDER and CBER to tackle review questions while directors Janet Woodcock and Peter Marks help lead Operation Warp Speed; regulatory community is 'reassured' they will oversee advancement of COVID-19 therapeutics and vaccines.

wooden figures of people. rivals in business stand on the scales. competition. trial. conflict. victory and defeat. bad and good worker. concept of success and power
Top FDA officials recuse themsleves from COVID-19 product review decisions

More from US FDA

More from Agency Leadership